SG11201802941TA - Dopamine d3 receptor antagonists having a morpholine moiety - Google Patents
Dopamine d3 receptor antagonists having a morpholine moietyInfo
- Publication number
- SG11201802941TA SG11201802941TA SG11201802941TA SG11201802941TA SG11201802941TA SG 11201802941T A SG11201802941T A SG 11201802941TA SG 11201802941T A SG11201802941T A SG 11201802941TA SG 11201802941T A SG11201802941T A SG 11201802941TA SG 11201802941T A SG11201802941T A SG 11201802941TA
- Authority
- SG
- Singapore
- Prior art keywords
- dopamine
- receptor antagonists
- morpholine moiety
- morpholine
- moiety
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Medicinal Chemistry (AREA)
- Neurology (AREA)
- Addiction (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1518124.1A GB2543296A (en) | 2015-10-13 | 2015-10-13 | Dopamine D3 receptor antagonists having a morpholine moiety |
| PCT/GB2016/053169 WO2017064488A1 (en) | 2015-10-13 | 2016-10-13 | Dopamine d3 receptor antagonists having a morpholine moiety |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201802941TA true SG11201802941TA (en) | 2018-05-30 |
Family
ID=55130992
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201802941TA SG11201802941TA (en) | 2015-10-13 | 2016-10-13 | Dopamine d3 receptor antagonists having a morpholine moiety |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US10577361B2 (en) |
| EP (1) | EP3362446B1 (en) |
| AU (1) | AU2016338992B2 (en) |
| CA (1) | CA3001649C (en) |
| DK (1) | DK3362446T3 (en) |
| ES (1) | ES2839407T3 (en) |
| GB (1) | GB2543296A (en) |
| IL (1) | IL258606B (en) |
| NZ (1) | NZ741384A (en) |
| SG (1) | SG11201802941TA (en) |
| WO (1) | WO2017064488A1 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11447484B2 (en) | 2018-01-26 | 2022-09-20 | Shionogi & Co., Ltd. | Cyclic compound having dopamine D3 receptor antagonistic effect |
| CN110407763B (en) * | 2019-08-08 | 2022-10-14 | 苏州汉德创宏生化科技有限公司 | Synthesis method of 4- (oxazole-2-yl) benzoic acid |
| CN116459341B (en) * | 2023-03-15 | 2024-03-19 | 徐州医科大学 | Application of dopamine 3 type receptor as target in developing or preparing non-opioid analgesic |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1058060B (en) * | 1956-09-12 | 1959-05-27 | Ravensberg G M B H Chmische Fa | Process for the preparation of substituted ªÏ-morpholinoalkyl ethers of salicylamide with analgesic activity |
| FR2094499A5 (en) * | 1970-06-23 | 1972-02-04 | Aries Robert | Phenoxyalkanoic acid morpholides - with hypocholesterolaemic and anorectic activity |
| JPS6061569A (en) * | 1983-09-16 | 1985-04-09 | Asahi Chem Ind Co Ltd | Novel amine derivative substitued in the 3-position |
| GB8720910D0 (en) * | 1987-09-05 | 1987-10-14 | Pfizer Ltd | Antiarrhythmic agents |
| JPH072848A (en) * | 1993-04-23 | 1995-01-06 | Sankyo Co Ltd | Morpholine and thiomorpholine derivatives |
| PL377480A1 (en) * | 2002-12-10 | 2006-02-06 | Pfizer Inc. | Morpholine derivatives for use as dopamine agonists in the treatment of i.a. sexual dysfunction |
| JP4198183B2 (en) * | 2004-05-27 | 2008-12-17 | ファイザー・インク | Aminopyridine derivatives as selective dopamine D3 agonists |
| GB0502509D0 (en) * | 2005-02-07 | 2005-03-16 | Pfizer Ltd | Novel salt form of a dopamine agonist |
| WO2008026046A1 (en) * | 2006-08-30 | 2008-03-06 | Pfizer Products Inc. | Morpholine d3 dopamine antagonists |
| GB0700786D0 (en) * | 2007-01-15 | 2007-02-21 | Pfizer Ltd | Morpholine dopamine agonists for the treatment of pain |
-
2015
- 2015-10-13 GB GB1518124.1A patent/GB2543296A/en not_active Withdrawn
-
2016
- 2016-10-13 US US15/767,328 patent/US10577361B2/en active Active
- 2016-10-13 CA CA3001649A patent/CA3001649C/en active Active
- 2016-10-13 ES ES16784245T patent/ES2839407T3/en active Active
- 2016-10-13 WO PCT/GB2016/053169 patent/WO2017064488A1/en active Application Filing
- 2016-10-13 NZ NZ741384A patent/NZ741384A/en unknown
- 2016-10-13 EP EP16784245.9A patent/EP3362446B1/en active Active
- 2016-10-13 SG SG11201802941TA patent/SG11201802941TA/en unknown
- 2016-10-13 DK DK16784245.9T patent/DK3362446T3/en active
- 2016-10-13 AU AU2016338992A patent/AU2016338992B2/en active Active
-
2018
- 2018-04-10 IL IL258606A patent/IL258606B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2016338992B2 (en) | 2020-10-08 |
| WO2017064488A1 (en) | 2017-04-20 |
| GB2543296A (en) | 2017-04-19 |
| CA3001649A1 (en) | 2017-04-20 |
| EP3362446B1 (en) | 2020-12-02 |
| EP3362446A1 (en) | 2018-08-22 |
| DK3362446T3 (en) | 2021-01-04 |
| CA3001649C (en) | 2023-04-04 |
| US20180297990A1 (en) | 2018-10-18 |
| GB201518124D0 (en) | 2015-11-25 |
| IL258606B (en) | 2022-02-01 |
| IL258606A (en) | 2018-06-28 |
| US10577361B2 (en) | 2020-03-03 |
| AU2016338992A1 (en) | 2018-04-26 |
| ES2839407T3 (en) | 2021-07-05 |
| NZ741384A (en) | 2022-11-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1250029A1 (en) | Dopamine d3 receptor antagonists having a bicyclo moiety | |
| IL276400A (en) | Dopamine d3 receptor antagonists compounds | |
| IL288907A (en) | Pharmaceutical combination comprising a selective s1p1 receptor agonist | |
| GB2585602B (en) | Arrangement for supporting a wellhead | |
| HK1244767A1 (en) | A dispenser | |
| IL258606B (en) | Dopamine d3 receptor antagonists having a morpholine moiety | |
| GB2563436B (en) | A device for electrolysis | |
| GB201718256D0 (en) | Ox1 antagonists | |
| SG11201700014XA (en) | A gasifier | |
| GB201416819D0 (en) | Base for a building | |
| GB201518125D0 (en) | Dopamine D3 receptor antagonist having a bicyclo moiety | |
| IL275179A (en) | Refill for a dispenser | |
| GB201419430D0 (en) | Dopamine D3 receptor antagonist compounds | |
| GB201419433D0 (en) | Dopamine D3 receptor antagonist compounds | |
| GB201617051D0 (en) | A feed supplemment | |
| GB201610785D0 (en) | A device for electrolysis | |
| GB201513871D0 (en) | Bicyclo dopamine D3 receptor antagonists | |
| GB201610078D0 (en) | A feeding device | |
| ZA201509348B (en) | A toilet | |
| HK1190564A2 (en) | A bowl holder | |
| GB201405134D0 (en) | Wobblegone: a leveling device | |
| GB201410577D0 (en) | Base for a building | |
| AU359831S (en) | A bowl | |
| GB201409094D0 (en) | A dispenser | |
| GB201415888D0 (en) | A Machine Tool |